2016 / 03

Следующая статья
DOI: 10.24075/brsmu.2016-03-04

МЕТОД

Мицеллярные композиции на основе функционализированных α-фетопротеином амфифильных блок-сополимеров, содержащих гадолиний и куркумин

Н. В. Позднякова1, Е. Ю. Григорьева1, А. Б. Шевелев2
Информация об авторах

1 Лаборатория радионуклидных и лучевых технологий в экспериментальной онкологии,
Российский онкологический научный центр имени Н. Н. Блохина, Москва

2 Лаборатория процессов фотосенсибилизации,
Институт биохимической физики имени Н. М. Эмануэля РАН, Москва

Для корреспонденции: Наталья Вячеславовна Позднякова
Каширское шоссе, д. 24, г. Москва, 115478; ur.liam@2002optan

Информация о статье

Финансирование: исследование поддержано Министерством образования и науки Российской Федерации (Соглашение о предоставлении субсидии № 14.607.21.0133 от 27.10.2015, уникальный идентификатор RFMEFI60715X0133).

Статья получена: 23.06.2016 Статья принята к печати: 27.06.2016 Опубликовано online: 05.01.2017
|
  1. Goischke HK. MRI with gadolinium-based contrast agents: practical help to ensure patient safety. J Am Coll Radiol. 2016 Jun 18. pii: S1546–1440(16)30315–5.
  2. Dinger SC, Fridjhon P, Rubin DM. Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance. PLoS One. 2016 Jun 24; 11 (6): e0158194.
  3. Saito K, Yoshimura N, Shirota N, Saguchi T, Sugimoto K., Tokuuye K. Distinguishing liver haemangiomas from metastatic tumours using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced diffusion-weighted imaging at 1.5T MRI. J Med Imaging Radiat Oncol. 2016 Jun 21. DOI: 10.1111/1754-9485.12487. [Epub ahead of print]. PubMed PMID: 27324436.
  4. Hu HH, Pokorney A, Towbin RB, Miller JH. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams. Pediatr Radiol. 2016 Jun 9. [Epub ahead of print]. PubMed PMID: 27282825.
  5. Schnell S, Wu C, Ansari SA. Four-dimensional MRI flow examinations in cerebral and extracerebral vessels — ready for clinical routine? Curr Opin Neurol. 2016 Aug; 29 (4): 419–28. [Epub ahead of print]. PubMed PMID: 27262148.
  6. Swoboda PP, McDiarmid AK, Erhayiem B, Haaf P, Kidambi A, Fent GJ, et al. A novel and practical screening tool for the detection of silent myocardial infarction in patients with type 2 diabetes. J Clin Endocrinol Metab. 2016 Jun 14. [Epub ahead of print]. PubMed PMID: 27300573.
  7. Kang MK, Lee GH, Jung KH, Jung JC, Kim HK, Kim YH, et al. Gadolinium Nanoparticles Conjugated with Therapeutic Bifunctional Chelate as a Potential T1 Theranostic Magnetic Resonance Imaging Agent. J Biomed Nanotechnol. 2016 May; 12 (5): 894–908.
  8. De León-Rodríguez LM, Martins AF, Pinho MC, Rofsky NM, Sherry AD. Basic MR relaxation mechanisms and contrast agent design. J Magn Reson Imaging. 2015 Sep; 42 (3): 545–65.
  9. Yang CT, Chuang KH. Gd(III) chelates for MRI contrast agents: from high relaxivity to “smart”, from blood pool to blood–brain barrier permeable. Medchemcomm. 2012; 3: 552–65.
  10. Maximova N, Gregori M, Zennaro F, Sonzogni A, Simeone R, Zanon D. Hepatic gadolinium deposition and reversibility after contrast agent-enhanced MR imaging of pediatric hematopoietic stem cell transplant recipients. Radiology. 2016 Jun 8: 152846. [Epub ahead of print]. PubMed PMID: 27276243.
  11. Vorobiov M, Basok A, Tovbin D, Shnaider A, Katchko L, Rogachev B. Iron-mobilizing properties of the gadolinium–DTPA complex: clinical and experimental observations. Nephrol Dial Transplant. 2003 May; 18 (5): 884–7.
  12. Ersoy H, Rybicki FJ. Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging. 2007 Nov; 26 (5): 1190–7.
  13. Le Duc G, Roux S, Paruta-Tuarez A, Dufort S, Brauer E, Marais A, et al. Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment. Cancer Nanotechnol. 2014; 5 (1): 4.
  14. Heger M, van Golen RF, Broekgaarden M, Michel MC. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharmacol Rev. 2013 Dec 24; 66 (1): 222–307.
  15. Pröhl M, Schubert US, Weigand W, Gottschaldt M. Metal complexes of curcumin and curcumin derivatives for molecular imaging and anticancer therapy. Coord Chem Rev. 2016 Jan 15; 307 (Pt 1): 32–41.
  16. Carstens MG, Rijcken CJF, van Nostrum CF, Hennink WE. Pharmaceutical micelles: combining longevity, stability and stimuli sensitivity. In: Fundamental Biomedical Technologies. Vol. 4: Torchilin V, editor. Multifunctional Pharmaceutical Nanocarriers. New York: Springer; 2008. p. 263–308.
  17. Oerlemans C, Bult W, Bos M, Storm G, Nijsen JF, Hennink WE. Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res. 2010 Dec; 27 (12): 2569–89.
  18. Alexandridis P, Hatton TA. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 1995 Mar 10; 96 (1–2): 1–46.
  19. Pozdniakova NV, Gorokhovets NV, Gukasova NV, Bereznikova AV, Severin ES. New protein vector ApE1 for targeted delivery of anticancer drugs. J Biomed Biotechnol. 2012; 2012: 469756.
  20. Ferrari E, Asti M, Benassi R, Pignedoli F, Saladini M. Metal binding ability of curcumin derivatives: a theoretical vs. experimental approach. Dalton Trans. 2013 Apr 21; 42 (15): 5304–13.
  21. Fields R. The rapid determination of amino groups with TNBS. Methods Enzymol. 1972; 25: 464–8.
  22. Kurfürst MM. Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem. 1992 Feb 1; 200 (2): 244–8.
  23. Crabb NT, Persinger HE. The determination of polyoxyethylene nonionic surfactants in water at the parts per million level. J Am Oil Chem Soc. 1964; 41 (11): 752–5.
  24. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct; 150 (1): 76–85.
  25. Chen L, Sha X, Jiang X, Chen Y, Ren Q, Fang X. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation. Int J Nanomedicine. 2013; 8: 73–84.
  26. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev. 1999 Sep 8; 99 (9): 2293–352.
  27. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A. 1998 Apr 14; 95 (8): 4607–12.
  28. Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev. 2011 Mar 18; 63 (3): 161–9.
  29. Patil R, Gangalum PR, Wagner S, Portilla-Arias J, Ding H, Rekechenetskiy A, et al. Curcumin targeted, polymalic acid-based MRI contrast agent for the detection of Aβ plaques in Alzheimer's disease. Macromol Biosci. 2015 Sep; 15 (9): 1212–7.
  30. Jhaveri AM, Torchilin VP. Multifunctional polymeric micelles for delivery of drugs and siRNA. Front Pharmacol. 2014 Apr 25; 5: 77.